Cannara Biotech IncTSXV:LOVEView on OTCQB
- LAST PRICE0.8400
- TODAY'S CHANGE (%)-0.0100 (-1.1765%)
- Bid / Lots0.8200/ 1
- Ask / Lots0.8600/ 2
- Open / Previous Close0.8400 / 0.8500
- Day Range
- 52 Week Range
- Volume3,620
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LOVE |
|---|---|---|
| 12:30 ET | 3500 | 0.84 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cannara Biotech Inc | 75.6M | 8.3x | --- |
C21 Investments Inc | 49.8M | -14.3x | --- |
Leef Brands Inc | 23.7M | -0.5x | --- |
Decibel Cannabis Company Inc | 53.2M | -13.9x | --- |
Lowell Farms Inc | 2.0M | 0.0x | --- |
IM Cannabis Corp | 10.4M | -1.1x | --- |
Company Information
Cannara Biotech Inc. is a Canada-based vertically integrated producer of premium-grade cannabis and cannabis-derivative products for the Quebec and Canadian markets. It operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. The Company owns two mega facilities based in Quebec spanning over 1,650,000 square feet, providing the Company with 100,000 kilograms of annualized cultivation output. It operates in two segments: Cannabis operations and Real estate operations. The Cannabis operations, which encompasses the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and other cannabis services (Cannabis operations). The Real estate operations, related to the Farnham and Valleyfield building (Real estate operations). The Company’s brand portfolio includes Tribal, Nugz, and Orchid CBD. Orchid CBD is a wellness brand that provides premium CBD-dominant cannabis.
Contact Information
- Headquarters
- Suite 2050 - 1055, West Georgia StreetVANCOUVER, BC, Canada V6E 3P3
- Phone
- 514-913-9136
- Fax
- 514-913-9136
Executives
- Chairman of the Board, Chief Executive Officer
- Zohar Krivorot
- Chief Financial Officer
- Nicholas Sosiak
- Chief Technology Officer
- Avi Krivorot
- Vice President - Finance
- Noemi Follain
- Vice President - Compliance, General Manager
- Anthony Manouk
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $75.6M |
|---|---|
Revenue (TTM) | $66.7M |
Shares Outstanding | 90.0M |
Cannara Biotech Inc does not pay a dividend. | |
Beta | 1.16 |
EPS | $0.10 |
Book Value | $0.88 |
P/E Ratio | 8.3x |
Price/Sales (TTM) | 1.1 |
Price/Cash Flow (TTM) | 5.2x |
Operating Margin | 21.33% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
